港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

医美概念股

1,268.165

-27.299-2.11%

涨家数：2

跌家数：7

平家数：4

市盈率：- -

高：1,295.716

开：1,295.716

低：1,264.657

收：1,295.464

成交量：2,907.08万

成交额：4.85亿

市值：2,073.45亿

流通市值：1,542.11亿

数据加载中...

双擎驱动破帕新生丨复星医药帕金森病创新治疗方案联合发布会成功举办

铸就"美丽供应链"：复锐医疗科技携手万邦医药、上药康德乐于进博舞台共启达希斐®物流合作签约仪式

昊海生物科技(06826)11月6日斥资74.69万港元回购2.71万股

每日卖空追踪 | 复星医药 11月06日卖空量成交4.2万股，卖空比例为1.52%

每日卖空追踪 | 康哲药业 11月06日卖空量成交79.9万股，卖空比例为20.76%

时代天使11月06日遭主力抛售282.4万元

康哲药业11月06日获主力加仓421.6万元

【券商聚焦】交银国际：11月起医药板块投资情绪有望企稳回升

中新健康丨2025年国谈收官 “天价抗癌疗法”或迎支付破局

中国新闻网

昊海生物科技(06826)11月5日斥资80.57万港元回购2.96万股

每日卖空追踪 | 时代天使 11月05日卖空量成交1.82万股，卖空比例为3.08%

每日卖空追踪 | 现代牙科 11月05日卖空量成交2000股，卖空比例为0.22%

每日卖空追踪 | 三生制药 11月05日卖空量成交213.35万股，卖空比例为8.63%

每日卖空追踪 | 四环医药 11月05日卖空量成交324.8万股，卖空比例为7.24%

三生制药11月05日主力净流入1337.3万元散户资金抛售

加码大健康！红杉中国抄底拜耳王牌业务

尚普并购咨询

对外授权及产品商业化驱动营收大幅增长

现代牙科集团03600.HK调研纪要：数码化与全球扩张并进，增长动能强劲

港股投研所

港交所谴责、高薪高管与31亿亏损，复宏汉霖治理迷思何解？

ORR 84%！复星医药MEK抑制剂“芦沃美替尼”新适应症拟优先审评

医药魔方Info

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1593/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"医美概念股","latestPrice":1268.1652,"timestamp":1762484880254,"preClose":1295.4637,"halted":0,"volume":29070809,"delay":0,"changeRate":-0.021072,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":-27.298584,"latestTime":"11-07 11:08:03","open":1295.7163,"high":1295.7163,"low":1264.6566,"amount":485288516,"amplitude":0.023976,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1762488000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1762479000000,1762488000000],[1762491600000,1762502400000]],"pbRate":1.859997,"peRate":26.701793,"turnoverRate":0.00146,"increases":2,"decrements":7,"flats":4,"marketCap":207344805008,"floatMarketCap":154211371920},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":1295.7163,"amplitude":0.023976,"preClose":1295.4637,"low":1264.6566,"pbRate":"1.859997","latestPrice":1268.1652,"volume":29070809,"delay":0,"open":1295.7163,"prevYearClose":571.87146,"prevWeekClose":1288.46,"prevMonthClose":1288.46,"prevQuarterClose":1308.644,"fiveDayClose":1288.46,"twentyDayClose":1283.488,"sixtyDayClose":1260.192,"secType":"PLATE","market":"HK","turnoverRate":0.00146,"peRate":26.701793,"marketCap":207344805008,"floatMarketCap":154211371920,"timestamp":1762484880254,"nameCN":"医美概念股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":2,"down":7,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2581002593","title":"双擎驱动 破帕新生丨复星医药帕金森病创新治疗方案联合发布会成功举办","url":"https://stock-news.laohu8.com/highlight/detail?id=2581002593","media":"复星医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581002593?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 22:58","pubTimestamp":1762441133,"startTime":"0","endTime":"0","summary":"11月6日，第八届中国国际进口博览会期间，复星医药以“双擎驱动，破帕新生”为主题，成功举办帕金森病创新治疗方案联合发布会。聚焦未被满足的临床需求，复星医药积极探索全球领先的创新解决方案。本次发布的“药械协同”帕金森病创新治疗方案，通过创新药物与先进医疗器械的有机结合，为帕金森病患者提供全新治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107014206a6e68217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107014206a6e68217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1593","02196","BK1515"],"gpt_icon":0},{"id":"2581001835","title":"铸就\"美丽供应链\"：复锐医疗科技携手万邦医药、上药康德乐于进博舞台共启达希斐®物流合作签约仪式","url":"https://stock-news.laohu8.com/highlight/detail?id=2581001835","media":"美通社","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581001835?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 18:27","pubTimestamp":1762424820,"startTime":"0","endTime":"0","summary":"通过汇聚复锐医疗科技的创新产品力、万邦医药在生物制品领域的专业质量管理能力，以及上药控股覆盖全国的强大商业网络，将为达希斐的成功上市与广泛可及奠定坚实基础。复锐医疗科技董事长兼执行董事刘毅先生表示：\"达希斐是我们布局中国医美市场的战略级产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4817603_ZH17603_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1100","BK1593","BK1585","01696"],"gpt_icon":0},{"id":"2581050442","title":"昊海生物科技(06826)11月6日斥资74.69万港元回购2.71万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2581050442","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581050442?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 17:43","pubTimestamp":1762422185,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，于2025年11月6日该公司斥资74.69万港元回购2.71万股，回购价格为每股27.52-27.58港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1593","06826","BK1161"],"gpt_icon":0},{"id":"2581002592","title":"每日卖空追踪 | 复星医药 11月06日卖空量成交4.2万股，卖空比例为1.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581002592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581002592?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:30","pubTimestamp":1762417826,"startTime":"0","endTime":"0","summary":"复星医药北京时间11月06日，涨0.98%，卖空量成交4.2万股，较上一交易日减少94.17%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110616335794f2ded0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110616335794f2ded0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","02196","BK1593"],"gpt_icon":0},{"id":"2581092014","title":"每日卖空追踪 | 康哲药业 11月06日卖空量成交79.9万股，卖空比例为20.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581092014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581092014?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:30","pubTimestamp":1762417815,"startTime":"0","endTime":"0","summary":"康哲药业北京时间11月06日，涨0.21%，卖空量成交79.9万股，较上一交易日减少61.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106163209a48cdb09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106163209a48cdb09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BYV24P56.USD","SG9999015952.SGD","IE00BVYPNP33.GBP","SG9999004220.SGD","IE00BVYPNQ40.USD","SG9999015978.USD","LU2488822045.USD","IE00BGHQDM52.EUR","SG9999015986.USD","BK1593","SG9999015945.SGD","IE00BMCWC346.EUR","BK1191","00867"],"gpt_icon":0},{"id":"2581065960","title":"时代天使11月06日遭主力抛售282.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581065960","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581065960?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:15","pubTimestamp":1762416936,"startTime":"0","endTime":"0","summary":"11月06日，时代天使股价收平报68.05元，成交金额2911.6万元，换手率0.25%，振幅3.38%，量比0.37。时代天使今日主力资金净流出282.4万元，连续3日净流出，上一交易日主力净流出159.0万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为66.67%，平均跌幅为1.32%。该股近5个交易日上涨5.37%，主力资金累计净流出152.1万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出99.4万元，其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106161849a48cd0b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106161849a48cd0b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1100","BK1583","BK1587","BK1593","06699"],"gpt_icon":0},{"id":"2581092092","title":"康哲药业11月06日获主力加仓421.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581092092","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581092092?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 16:15","pubTimestamp":1762416934,"startTime":"0","endTime":"0","summary":"11月06日, 康哲药业股价涨0.21%，报收14.08元，成交金额5398.6万元，换手率0.16%，振幅2.35%，量比0.45。康哲药业今日主力资金净流入421.6万元，上一交易日主力净流入48.8万元。该股近5个交易日上涨5.16%，主力资金累计净流出1001.9万元；近20日主力资金累计净流出1373.8万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511061618319757b38c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511061618319757b38c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","IE00BYV24P56.USD","IE00BMCWC346.EUR","LU2488822045.USD","IE00BVYPNP33.GBP","SG9999015945.SGD","SG9999015986.USD","IE00BGHQDM52.EUR","SG9999015978.USD","00867","IE00BVYPNQ40.USD","SG9999004220.SGD","BK1593","SG9999015952.SGD"],"gpt_icon":0},{"id":"2581008217","title":"【券商聚焦】交银国际：11月起 医药板块投资情绪有望企稳回升","url":"https://stock-news.laohu8.com/highlight/detail?id=2581008217","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581008217?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 09:08","pubTimestamp":1762391319,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，医药行业板块3Q25业绩呈现边际复苏态势，其中与创新产业链关联紧密的化药/生物药公司和CXO板块表现较优，集采影响逐步出清的子板块也有改善迹象。10月港股医药回调主因情绪回落和资金获利了结，但板块基本面不变、依旧强劲向好；11月起，行业催化剂增多（各项学术大会、BD出海交易、利好政策落地、潜在降息等），板块投资情绪有望企稳回升。该机构继续推荐关注以下细分方向：1）创新药：三生制药、德琪医药短期催化剂丰富、估值仍未反映核心大单品价值；先声药业、和黄医药、传奇生物被明显低估、长期成长逻辑清晰；2）CXO：受益于下游高景气度和融资边际回暖的细分赛道龙头，如药明合联。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1969115","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014674.SGD","LU1251922891.USD","LU0348825331.USD","LU1794554557.SGD","LU2476274308.USD","LU2778985437.USD","IE00B5MMRT66.SGD","LU1115378108.SGD","01099","LU2328871848.SGD","BK1588","LU1770034418.SGD","03933","09939","LU0417516738.SGD","09688","LU0540923850.HKD","LU0634319403.HKD","BK1617","LU1719994722.HKD","IE00B543WZ88.USD","159938","01530","LU0348735423.USD","LU1303224171.USD","BK1141","01789","03329","SG9999004311.SGD","LU0561508036.HKD","LU0640798160.USD","09926","BK1161","LU2488822045.USD","BK1207","06160","LU1961090484.USD","02268","LU0348784397.USD","LU1720050803.USD","BK1585","LU0348783233.USD","02228","LU0348827113.USD","LU0417516902.SGD","BK1191","02196","BK1500","02367","BK1593"],"gpt_icon":0},{"id":"2581739747","title":"中新健康丨2025年国谈收官 “天价抗癌疗法”或迎支付破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2581739747","media":"中国新闻网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581739747?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 19:08","pubTimestamp":1762340901,"startTime":"0","endTime":"0","summary":"国家医保局8月公布了2025年国家基本医疗保险、生育保险和工伤保险药品目录及商业健康保险创新药品目录调整形式审查的申报药品名单。“天价抗癌疗法”或迎来支付破局在今年的商保创新药目录中，天价“CAR-T疗法”无疑成为最大看点。截至目前，国内已有7款CAR-T疗法获批上市，定价普遍在百万元以上，此次有5款CAR-T疗法通过了商保目录的形式审查，其中3款同时申报了两个目录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105190826a6e30a05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105190826a6e30a05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06978","BK1593","02126","02196","BK1191","BK1161","BK1515","02171","BK1574"],"gpt_icon":0},{"id":"2581741465","title":"昊海生物科技(06826)11月5日斥资80.57万港元回购2.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2581741465","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581741465?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:57","pubTimestamp":1762333079,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生物科技(06826)发布公告，该公司于2025年11月5日斥资80.57万港元回购2.96万股股份，每股回购价格为27-27.36港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365547.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1593","BK1161"],"gpt_icon":0},{"id":"2581621722","title":"每日卖空追踪 | 时代天使 11月05日卖空量成交1.82万股，卖空比例为3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581621722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581621722?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:30","pubTimestamp":1762331435,"startTime":"0","endTime":"0","summary":"时代天使北京时间11月05日，涨1.26%，卖空量成交1.82万股，较上一交易日减少85.08%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163531a6e2ad72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163531a6e2ad72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","06699","BK1100","BK1587","BK1583"],"gpt_icon":0},{"id":"2581772541","title":"每日卖空追踪 | 现代牙科 11月05日卖空量成交2000股，卖空比例为0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581772541","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581772541?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:30","pubTimestamp":1762331433,"startTime":"0","endTime":"0","summary":"现代牙科北京时间11月05日，涨0.36%，卖空量成交2000股，较上一交易日减少92.59%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163509a6e2ad38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163509a6e2ad38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03600","BK1593","BK1583","BK1100"],"gpt_icon":0},{"id":"2581872390","title":"每日卖空追踪 | 三生制药 11月05日卖空量成交213.35万股，卖空比例为8.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581872390","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581872390?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:30","pubTimestamp":1762331422,"startTime":"0","endTime":"0","summary":"三生制药北京时间11月05日，涨1.27%，卖空量成交213.35万股，较上一交易日减少48.52%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163258a6e2abd6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105163258a6e2abd6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","BK1583","01530"],"gpt_icon":0},{"id":"2581207357","title":"每日卖空追踪 | 四环医药 11月05日卖空量成交324.8万股，卖空比例为7.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581207357","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581207357?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:30","pubTimestamp":1762331413,"startTime":"0","endTime":"0","summary":"四环医药北京时间11月05日，跌2.74%，卖空量成交324.8万股，较上一交易日减少1.46%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516311297555c67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110516311297555c67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00460","BK1600","BK1593","BK1191","BK1515"],"gpt_icon":0},{"id":"2581087442","title":"三生制药11月05日主力净流入1337.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2581087442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581087442?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:16","pubTimestamp":1762330564,"startTime":"0","endTime":"0","summary":"11月05日, 三生制药股价涨1.27%，报收30.30元，成交金额7.4亿元，换手率1.02%，振幅6.22%，量比0.62。三生制药今日主力资金净流入1337.3万元，上一交易日主力净流出2092.0万元。该股近5个交易日上涨7.78%，主力资金累计净流入2.4亿元；近20日主力资金累计净流入2.7亿元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105162303975557f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105162303975557f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1161","01530","BK1593"],"gpt_icon":0},{"id":"2581742607","title":"加码大健康！红杉中国抄底拜耳王牌业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2581742607","media":"尚普并购咨询","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581742607?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 16:14","pubTimestamp":1762330447,"startTime":"0","endTime":"0","summary":"截至目前，已通过仿制药一致性评价的莫西沙星在中国市场上已有数十款产品。因此，原研药拜复乐在医院市场的份额也急剧下降，但仍占据中国市场40%的份额，展现出强大的品牌认可度。从上半年的业绩来看，其制药业务已率先逐步恢复增长。根据协议，亿帆医药获得了这两款药物在中国大陆地区的独家市场推广权益。与以往不同的是，中国资本已崛起为过期专利药资产交易的关键参与者。无论是此次红杉中国收购拜耳Av","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105174905a48a43ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105174905a48a43ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BMCWC346.EUR","SG9999015945.SGD","BK1593","IE00BGHQDM52.EUR","00867","SG9999015986.USD","BK1191","01177","SG9999015952.SGD","SG9999015978.USD","SG9999004220.SGD","LU2488822045.USD","IE00BYV24P56.USD","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP"],"gpt_icon":0},{"id":"2581177429","title":"对外授权及产品商业化驱动营收大幅增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2581177429","media":"东方财富","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581177429?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 11:01","pubTimestamp":1762311707,"startTime":"0","endTime":"0","summary":"智翔金泰核心观点对外授权及产品商业化驱动营收大幅增长。感染类抗体产品与康哲药业达成合作。根据协议条款，智翔金泰将负责两个产品在中国的研发、注册、生产及与产品注册相关的工作；康哲药业将负责该产品在中国的所有商业化活动，以及除中国之外的亚太地区及中东、北非区域的注册与商业化等工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105110149a489553a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105110149a489553a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","IE00BVYPNQ40.USD","BK1191","IE00BYV24P56.USD","SG9999004220.SGD","IE00BVYPNP33.GBP","SG9999015952.SGD","SG9999015978.USD","IE00BGHQDM52.EUR","00867","LU2488822045.USD","SG9999015945.SGD","IE00BMCWC346.EUR","SG9999015986.USD"],"gpt_icon":0},{"id":"2581521772","title":"现代牙科集团03600.HK调研纪要：数码化与全球扩张并进，增长动能强劲","url":"https://stock-news.laohu8.com/highlight/detail?id=2581521772","media":"港股投研所","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581521772?lang=zh_cn&edition=fundamental","pubTime":"2025-11-05 09:23","pubTimestamp":1762305781,"startTime":"0","endTime":"0","summary":"今年10月，现代牙科集团在东莞松山湖生产基地组织了一场调研活动。目前集团的分销管道遍布全球28个国家，活跃医生用户逾35,000位，有望进一步整合市场，持续提升渗透率。集团在数码化制造、人才培养及市场扩张方面的努力，有望在未来持续驱动其业绩稳健增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105111901a4895f90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105111901a4895f90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03600","BK1100","BK1583","BK1593"],"gpt_icon":0},{"id":"2581765334","title":"港交所谴责、高薪高管与31亿亏损，复宏汉霖治理迷思何解？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581765334","media":"伯达财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581765334?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 23:56","pubTimestamp":1762271770,"startTime":"0","endTime":"0","summary":"然而，复宏汉霖并未主动将这笔投资公之于众。2025年9月2日，港交所的一纸谴责公告，将复宏汉霖这项理财投资的细节和盘托出。复宏汉霖受到港交所谴责，而刘世高受到批评，并且要求刘世高接受26小时有关监管和法律议题以及上市规则合规事宜的培训，才能再获委任为任何已于或将于联交所上市的公司董事。特别是在港交所因资金管理问题对公司进行公开谴责的背景下，高昂的高管","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105001328a6e0e370&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105001328a6e0e370&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02196","BK1515","BK1191","02696","BK1161","BK1593"],"gpt_icon":0},{"id":"2580773006","title":"ORR 84%！复星医药MEK抑制剂“芦沃美替尼”新适应症拟优先审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2580773006","media":"医药魔方Info","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580773006?lang=zh_cn&edition=fundamental","pubTime":"2025-11-04 20:58","pubTimestamp":1762261093,"startTime":"0","endTime":"0","summary":"11月4日，CDE网站显示，复星医药自主研发的芦沃美替尼的新适应症拟纳入优先审评，用于2岁及2岁以上朗格汉斯细胞组织细胞增生症儿童患者。芦沃美替尼是复星医药自主研发的创新型小分子MEK1/2选择性抑制剂，通过阻断MAPK信号通路的异常激活，抑制肿瘤细胞增殖并诱导其凋亡。今年EHA大会上，芦沃美替尼用于儿童LCH的II期研究成果以壁报形式发布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104214559a487f64d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104214559a487f64d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","BK1593","02196"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":114,"code":"91000000","status":"200"}]}}